Abstract. Cordycepin (3'-deoxyadenosine), a major bioactive compound of Cordyceps militaris, has many pharmacological actions, such as anti-inflammatory and anticancer activities. In this study, the relationship between inhibition of cell motility and anti-invasive activity by cordycepin in LNCaP human prostate carcinoma cells was investigated. Within the concentration range that was not cytotoxic, cordycepin time-dependently inhibited cell motility and invasiveness of LNCaP cells. The inhibitory effects of cordycepin on cell invasiveness were associated with tightening of tight junctions (TJs), which was demonstrated by an increase in transepithelial electrical resistance (TER). Immunoblotting indicated that cordycepin decreases levels of claudin proteins, which are major components of TJs that play a key role in control and selectivity of paracellular transport. Furthermore, cordycepin inhibited the expression and activity of matrix metalloproteinase (MMP)-2 and MMP-9, and simultaneously increased levels of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. These effects were related to inactivation of the phosphoinositide 3-kinase (PI3K)/Akt pathway in LNCaP cells. These findings suggest that cordycepin inhibits the migration and invasion of LNCaP cells by downregulating the activity of TJs and MMPs, possibly in association with suppression of Akt activation.
Introduction
Metastasis is a process by which cancer spreads from the place at which it first arose as a primary tumor to distant locations in the body. The process involves several steps: invasion of adjacent tissues, intravasation, transport of cancer cells through the circulatory system, arrest at a secondary site, extravasation, and growth in a secondary organ. In epithelial cells, several specialized and distinct intercellular structures, including the gap junction, tight junction (TJ), adherens junction (AJ), and desmosome, are responsible for establishment of contact between neighboring cells. Among these, TJs, situated at the membrane between apical and lateral regions of polarised epithelial cells, selectively regulate the passage of molecules and ions via the paracellular pathway, and also restrict the lateral movement of molecules in the cell membrane (1, 2) . In precancerous lesions of the epithelia and cancerous epithelia, TJ strands become disorganized or lost altogether and TJs become 'leaky', as indicated by decreased resistance to electrical current (measured by transepithelial electrical resistance; TER) and increased markers of paracellular permeability (1, 3, 4) . Claudins, which are major integral membrane proteins that form the backbone of TJs, can form homodimers or heterodimers to produce paired strands between adjacent cells and act as a barrier to the paracellular flux of water, solution and transmigration of other cells, thereby determining the characteristic permeability properties of different epithelial tissues (5-7). Recent studies have provided evidence that claudins are aberrantly expressed in various cancers and are associated
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with development and progression of cancer, which suggests that they have key cellular functions that are distinct from their roles in TJ-complexes (8) (9) (10) . The matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases, play an important role in inflammatory tissue destruction, angiogenesis, and cancer cell metastasis. In cancer cells, these enzymes may contribute to cell invasion favoring modifications to the matrix, resulting in tumor cell invasion (11, 12) . Invasive cancer cells utilize MMPs to degrade the extracellular matrix (ECM) and basement membrane during metastasis. Among the human MMPs reported to date, the enzymes gelatinases A (MMP-2) and B (MMP-9), which are expressed abundantly in various malignant tumors, contribute to cancer invasion and metastasis. Generally, MMP-2 (72 kDa) is preferentially secreted from fibroblasts and various epithelial cells, while MMP-9 (92 kDa) is preferentially expressed by inflammatory cells, and both have been frequently associated with the invasive metastatic potential of tumor cells (13, 14) . The so-called tissue inhibitors of metalloproteinases (TIMPs), which are naturally occurring inhibitors of MMPs, play an important role in the complex regulation of MMPs. They inhibit the catalytic activity of MMPs by binding to activated MMPs and control breakdown of ECM (15, 16) . Thus, the balance between MMPs and TIMPs plays a vital role in maintaining the integrity of healthy tissues, and MMP inhibitors, as well as TIMP activators, are expected to be useful chemotherapeutic agents for the treatment of malignancies.
Cordycepin (3'-deoxyadenosine), a derivative of the nucleoside adenosine, is a major functional component in the Cordyceps militaris fungus (17, 18) , which belongs to the class Ascomycetes and has been widely used for a long time in traditional Chinese medicine. Due to the absence of oxygen in the 3' position of its ribose moiety, the incorporation of cordycepin during RNA synthesis results in termination of chain elongation. This activity has been well described in vitro with purified RNA polymerases and poly(A) polymerases from a number of organisms, including yeast and mammals (19, 20) . Although the roles and mechanisms of cordycepin as a potential chemotherapeutic agent have not been completely elucidated, several recent studies have indicated that cordycepin inhibits growth of cancer cells and induces apoptotic cell death (21) (22) (23) (24) (25) . However, the molecular mechanisms underlying the anti-metastatic effects of cordycepin are not yet completely understood.
Therefore, in this study, we attempted to elucidate the antimetastatic potential of cordycepin using an LNCaP human prostate carcinoma cell line and the underlying intracellular signal transduction pathways involved in inhibition of metastasis. Results of this study demonstrated that cordycepin inhibits two aspects of metastatic potential, cell motility and invasiveness, through modulation of the levels of TJ-associated factors and the activities of MMPs.
Materials and methods
Cell culture and MTT assay. LNCaP human prostate carcinoma cells were obtained from the American Type Culture Collection (Rockville, MD, USA) and cultured in RPMI-1640 supplemented with 10% fetal bovine serum (FBS) (Gibco BRL, Gaithersburg, MD, USA) and 1% penicillin-streptomycin at 37˚C in a humidified 95% air and 5% CO 2 . Cordycepin (SigmaAldrich Chemical Co., St Louis, MO, USA) was dissolved in distilled water as a stock solution at a 1 mg/ml concentration and was stored in aliquots at -20˚C. For the cell viability study, LNCaP cells were grown to 70% confluence and treated with cordycepin. Following treatment, cell viability was determined by 3-(4,5-dimethyl-2 thiazolyl)-2,5-diphnyl-2H-tetrazolium bromide (MTT) (Sigma-Aldrich) assay, which is based on conversion of MTT to MTT-formazan by mitochondria.
Wound healing migration assay. LNCaP cells were grown to confluence on 30-mm cell culture dishes coated with 20 µg/ ml of rat tail collagen (BD Biosciences, Bedford, MA, USA). Confluent cells were wounded by scraping with a pipette tip. After wounding, cultures were washed twice with PBS and control cells were exposed to medium alone. The cells were incubated with 1% FBS-containing medium supplemented with various concentrations of cordycepin for 48 h. Wound closure of cells was observed and photographed under the microscope at x40 magnification. The culture treatments were repeated twice and each sample was assayed in triplicate (26) . (27) .
Measurement
In vitro invasiveness assay. Matrigel invasion assays were used for assessment of the ability of LNCaP cells to penetrate ECM in the presence or absence of cordycepin. Briefly, cells were exposed to 5 or 10 µg/ml of cordycepin for 6 h, and treated cells (50,000) were then plated onto the apical side of Matrigelcoated filters in serum-free medium containing 5 or 10 µg/ml of cordycepin. Medium containing 20% FBS was placed in the basolateral chamber to function as a chemoattractant. After 48 h, cells on the apical side were wiped off with a Q-tip. Cells on the bottom of the filter were stained with hematoxylin and eosin Y (Sigma) and counted (three fields of each triplicate filter) using an inverted microscope.
RNA extraction and reverse transcription-PCR. Total RNA was prepared using an RNeasy kit (Qiagen, La Jolla, CA, USA) and primed with random hexamers for synthesis of complementary DNA using AMV reverse transcriptase (Amersham Corp., Arlington Heights, IL, USA), according to the manufacturer's instructions using DNAse I (1 U/µg RNA) pretreated total mRNA. Polymerase chain reaction (PCR) was carried out in a Mastercycler (Eppendorf, Hamburg, Germany) using the primers indicated in Table I . Conditions for PCR reactions were 1x (94˚C for 3 min), 35x (94˚C for 45 sec; 58˚C for 45 sec; and 72˚C for 1 min), and 1x (72˚C for 10 min). Amplification products obtained by PCR were electrophoretically separated on 1% agarose gel and visualized by ethidium bromide (EtBr) staining.
Protein extraction and western blot analysis. Total cell lysates were prepared in an extraction buffer [25 mM Tris-Cl (pH 7.5), 250 mM NaCl, 5 mM ethylendiaminetetra acetic acid, 1% nonidet P-40, 0.1 mM sodium orthovanadate, 2 µg/ml leupeptin, and 100 µg/ml phenylmethylsulfonyl fluoride]. Protein concentration was determined using a Bio-Rad protein assay kit (Bio-Rad, Laboratories, Hercules, CA, USA). For western blot analysis, proteins (30-50 µg) were separated by 8-10% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and then electrotransferred to a nitrocellulose membrane (Schleicher & Schuell, Keene, NH, USA). Membranes were blocked with 5% skim milk for 1 h, and were then subjected to immunoblot analysis using the desired antibodies. Proteins were then visualized by the enhanced chemiluminescence (ECL) method, according to the recommended procedure (Amersham Co.). Primary antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA) and Calbiochem (Cambridge, MA, USA). Peroxidase-labeled donkey anti-rabbit immunoglobulin and peroxidase-labeled sheep anti-mouse immunoglobulin were obtained (Amersham Co.).
Gelatin zymographic analysis of secreted MMPs. Following incubation with cordycepin for 48 h, cell culture supernatants were collected and centrifuged at 400 x g for 5 min. Cell-free supernatant was mixed with 2X sample buffer (Invitrogen) and zymography was performed using precast gels (10% polyacrylamide and 0.1% gelatin). Following electrophoresis, gels were washed twice at room temperature for 30 min in 2.5% Triton X-100, subsequently washed in buffer containing 50 mM Tris-HCl, 150 mM NaCl, 5 mM CaCl 2 , 1 µM ZnCl 2 , and 0.02% NaN 3 at pH 7.5 and incubated in this buffer at 37˚C for 24 h. Thereafter, gels were stained with 0.5% (w/v) Coomassie brilliant blue G-250 (Bio-Rad) for 1 h, then lightly destained in methanol/acetic acid/water (3:1:6). Clear bands appear on the Coomassie stained blue background in areas of gelatinolytic activity. Gels were scanned and images were processed by extraction of the blue channel signal, converting it to black and white, and inverting it for quantification of gelatinolytic activities from the integrated optical density (28) .
Statistical analysis. All data are presented as mean ± S.D. Significant differences among the groups were determined using the unpaired Student's t-test. A value of p<0.05 was accepted as an indication of statistical significance. All of the figures shown herein were obtained from at least three independent experiments.
Results

Cordycepin inhibits cell growth and migration of LNCaP cells.
In order to investigate the effect of cordycepin on the viability of LNCaP cells, cells were treated with various concentrations of cordycepin for 48 h and subjected to MTT assay. When compared with the control, treatment with 20 µg/ml cordycepin caused approximately 49% inhibition of cell growth. However, cordycepin in the range of 2-10 µg/ ml did not have a significant cytotoxic effect on LNCaP cells (Fig. 1A) . Therefore, a concentration of cordycepin within this lower range was used in the remaining experiments. To investigate the inhibitory effect of cordycepin on migration of LNCaP cells, an in vitro wound healing assay was performed. Results demonstrated that 10 µg/ml cordycepin, which was not cytotoxic, as shown by MTT assay, time-dependently delayed the motility of LNCaP cells compared to that of control cells (Fig. 1B) .
Cordycepin increased TER values and decreased cell invasion by LNCaP cells.
To examine the relationship between function of TJs and the anti-invasive activity of LNCaP cells treated with cordycepin, TER values were measured. As shown in Fig. 2A incubation of cells with cordycepin substantially increased their TER levels in a dose-dependent manner, suggesting that cordycepin increases tightening of TJs in LNCaP cells. Using a Boyden chamber invasion assay, we next attempted to determine whether the inhibitory effects of cordycepin were connected to the decreases in cell invasion. As shown in Fig. 2B and C, cordycepin treatment resulted in markedly reduced cell invasion through the Matrigel chamber in a concentration-dependent manner, suggesting that the inhibitory effects of cell migration are associated with inhibition of invasive activity in LNCaP cells. Cordycepin modulated the expression levels of TJ-related proteins in LNCaP cells. To elucidate the mechanism by which cordycepin enhances TJ activity and reduces invasive activity, we determined the levels of TJs and adherens junction (AJ) components, as well as TJ regulators such as claudins (claudin-2, -3, -4 and -5), E-cadherin and Snail, using RT-PCR and western blot analysis. As shown in Fig. 3 , the levels of claudins (claudin-2, -3, -4 and -5), the most important components of the TJ, were dose-dependently downregulated in cordycepin-treated cells at the transcriptional and translational levels, suggesting that this modulation contributes to TJ tightening. In addition, the levels of snail, an EMT regulator and zinc finger transcription factor (29, 30) , were markedly inhibited by cordycepin treatment. However, those of E-cadherin, a type Ⅰ transmembrane glycoprotein that regulates TJ and AJ formation (31,32), remained unchanged.
Cordycepin inhibits activation and expression of MMPs in LNCaP cells.
Since activating MMPs is crucial for ECM degradation, which is required for metastasis (11, 12) , we tested the effects of cordycepin on activation and expression of MMPs using gelatin zymography, RT-PCR and western blot analyses. Data indicated that activities of MMP-2 and -9 in LNCaP cells were significantly decreased by cordycepin treatment, which was connected with a concurrent downregulation of their mRNA and protein levels (Fig. 4) . However, cordycepin treatment markedly increased TIMP-1 and -2 mRNA and protein levels in a concentration-dependent manner. These results indicate that the anti-invasive effect of cordycepin is associated with increased TIMP levels, as well as inhibition of MMP-2 and -9 mRNA, protein expression, and activity in LNCaP cells.
Increase in cordycepin-induced anti-invasiveness by inhibition of the PI3K/Akt signal pathway. Several lines of evidence have implicated phosphoinositide 3-kinase (PI3K)/Akt in regulating
MMPs and TJs, which have been implicated in a number of cellular functions including cell survival, adhesion and metastasis (33, 34) . Therefore, the effects of cordycepin on the phosphorylation status of Akt in LNCaP cells were investigated. Data demonstrated that cordycepin treatment markedly decreases the phosphorylation of Akt in a concentration-dependent manner (Fig. 5A ). We then evaluated the possible role of PI3K/Akt signaling in cordycepin-induced anti-invasive activity. As shown in Fig. 5B-D , cordycepin-mediated downregulation of MMP 
untreated control). (B)
Cells were grown to confluency on 30-mm cell culture dishes; a scratch was then made through the cell layer using a pipette tip. After washing with PBS, serum free media (to prevent cell proliferation) containing either vehicle or cordycepin (10 µg/ml) was added for the indicated times. Images of the wounded area were taken for evaluation of cell movement into the wounded area. expression as well as anti-invasiveness were significantly suppressed by the Akt inhibitor (LY294002), which indicates that cordycepin-induced inhibition of invasion is mediated through the suppression of the PI3K/Akt pathway.
Discussion
Cancer cell migration and invasion are critical steps during metastasis; therefore, inhibition of cell migration and invasion are important mechanisms for consideration in the development of anti-metastatic drugs. In the present study, it was investigated whether or not cordycepin, a major active component of C. militaris, has potent anti-metastatic activities in LNCaP human prostate carcinoma cells. We found that cordycepin inhibited cell motility and invasive activity by the tightening of TJs and decreasing MMP activity, which is associated with inhibition of the PI3K/Akt pathway.
Recently, a frequent association of the development of human cancer with failure of epithelial cells to form TJs and to establish correct apicobasal polarity has become increasingly Figure 3 . Effects of cordycepin on expression of claudins, E-cadherin, and snail in LNCaP cells. (A) Cells were treated with the indicated concentrations of cordycepin for 48 h. Total RNA was isolated and reverse-transcribed using the indicated primers. Resulting cDNAs were then subjected to PCR and the reaction products were subjected to electrophoresis in a 1% agarose gel and visualized by EtBr staining. GAPDH was used as an internal control. (B) Cells grown under the same conditions as (A) were sampled, lysed, and 50 µg of proteins were separated by electrophoresis on SDS-polyacrylamide gels. Western blotting was then performed using the indicated antibodies, and an ECL detection system. Actin was used as an internal control. After incubation with cordycepin under the same conditions as those of (A), total RNA was isolated and reverse-transcribed. Resulting cDNAs were then subjected to PCR. The reaction products were subjected to electrophoresis in a 1% agarose gel and visualized by EtBr staining. GAPDH was used as an internal control. (C) Cells grown under the same conditions as (A) were sampled, lysed, and 50 µg of proteins were separated by electrophoresis on SDS-polyacrylamide gels. Western blotting was then performed using the indicated antibodies, and an ECL detection system. Actin was used as an internal control.
clear (1, 2) . These data suggest that changes in permeability and loss of cell polarity are hallmarks of epithelial cell tumorigenesis. TJs are critical structures in the maintenance of these functions in epithelial cells, and their modulation is observed in a number of epithelial cancers, indicating that disruption of TJs and dysregulation of their constituent proteins play critical roles in cancer progression, invasion, and metastasis (2, 4) . Several previous studies have shown that many anticancer agents are inhibitory to motility and invasiveness, and that they act by enhancement of transepithelial paracellular permeability (1, (35) (36) (37) (38) . Our results show that treatment with non-toxic concentrations of cordycepin increases the TER of LNCaP cells in a dose-dependent manner, which is associated with inhibition of cell motility and invasiveness ( Figs. 1 and 2) . These results imply that the inhibitory effects of cordycepin on migration and invasion of LNCaP cells are not due to its cytotoxic effect and indicates that cordycepin may prevent or reverse leakage of TJs. Since, leakage of TJs is tightly associated with the process of cancer metastasis, tightening of TJs may be expected to have anticancer activity. Thus, the antiinvasive activity of cordycepin may be due, in part, to its ability to enhance TJ activity.
Among the many components of TJs, members of the claudin family, which are transmembrane proteins with extracellular domains, interact with other claudins associated with adjacent cells in the regulation of paracellular permeability (5, 7, 15) . Emerging evidence indicates that disruption of TJs, with concomitant dysregulation of TJ proteins, is an early event in cancer cell invasion and metastasis (8) (9) (10) . In particular, overexpression of claudin-3 and -4 has been demonstrated in several tumors, including breast and ovarian cancers (36) . Conversely, 'knockdown' of these two claudins inhibited the invasiveness of cancer cells (37) . We also recently showed that claudin-1 plays a causal role in acquisition of invasive capacity in human liver cells, which is associated with increased expression of MMP-2. However, small interfering RNA targeting of claudin-1 in invasive hepatocellular carcinoma cells completely inhibited cell invasion (38) . These observations indicate that claudin proteins may prove to be useful biomarkers for detection and diagnosis of certain cancers. In the present study, we showed that cordycepin significantly inhibited expression of claudin family proteins (claudin-2, -3, -4 and -5) in a concentration-dependent fashion (Fig. 3) . In addition, E-cadherin, an adherens junction protein and a typeⅠ transmembrane glycoprotein (32) , is also known to regulate TJ formation (39) . Moreover, the EMT regulator, snail, can also lead to decreased cell-cell adhesion and increased cell invasiveness in conjunction with the loss of E-cadherin expression, in many types of human cancers (29, 40) . In our results, the levels of snail, but not E-cadherin, were gradually downregulated by cordycepin treatment. Although we need to validate this study, we tentatively suggest that cordycepin, through effects on the expression of snail, may mediate anti-metastasis and anti-invasiveness in LNCaP cells. MMPs are important proteolytic enzymes in organ development and tissue regeneration; however, they also play important roles in cancer cell invasion. In particular, MMP-2 and -9 play important roles in tumor invasion and angiogenesis; therefore, tumor metastasis can be inhibited by blocking MMP synthesis and activity (13, 14) . The activity of MMPs is tightly controlled by transcriptional activation, by a complex proteolytic activation cascade, and by an endogenous system of TIMPs. TIMPs inhibit MMPs by formation of stoichiometric complexes for regulation of matrix turnover (15, 16) . Therefore, we next determined whether the anti-invasive effects of cordycepin were associated with modulation of TIMP and MMP expression or activity. Our results indicate that cordycepin markedly inhibits the expression of MMP-2 and MMP-9 mRNA and protein levels, as well as their enzymatic activities. On the contrary, the transcriptional and translational levels of both TIMP-1 and TIMP-2 showed concentration-dependent upregulation in response to cordycepin treatment. The present data demonstrate that cordycepin-induced inhibition of cell motility and invasion is related to downregulation of MMP-2 and -9 activities through elevation of TIMPs expression. Therefore, our results suggest that cordycepin induces an increase in the TIMPs/MMPs ratio as a key factor in regulation of the antimetastatic process, which subsequently blocks degradation of the ECM and leads to inhibition of cell invasion.
Although the PI3K/Akt signal pathways play a critical role in regulating cell survival and death in many physiological and pathological settings, numerous studies have demonstrated that expression of TJs and MMPs are critically mediated by the PI3K/Akt pathways, suggesting that these pathways also play an important role in tumor metastasis (33, 34, 41) . Thus, we confirmed the involvement of the PI3K/Akt pathway in cordycepin-induced anti-invasive activity using LY294002, a representative PI3K/Akt inhibitor. As indicated in Fig. 5 , phosphorylated-Akt levels were decreased by cordycepin treatment in a concentration-dependent manner, and combined exposure with LY294002 made the cells more sensitive to cordycepin-induced downregulation of MMPs and inhibition of cell invasion. Therefore, we suggest that cordycepin inhibition of cell invasion of LNCaP cells might partly occur by suppressing the PI3K/Akt pathway.
In conclusion, the results of our studies provide mechanistic evidence that cordycepin inhibits cell motility and invasion of LNCaP human prostate carcinoma cells by increasing TJ activity and downregulation of MMP activity through Akt dephosphorylation. However, additional in vivo studies are needed to establish the role of cordycepin as an anti-metastatic agent for treatment of cancer.
